MedTrace Logo

Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS)

NCT05295537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-03-01

No results posted yet for this study

Summary

Although the use of liver biopsy (LB) has decreased with the emerging non-invasive markers and techniques to evaluate liver fibrosis, histopathologic examination of liver tissue is necessary to confirm the type of liver injury. The aim of our study is to compare two methods for obtaining histological material from the liver: the percutaneous liver biopsy (PLB) and the Endoscopic ultrasound (EUS) guided liver biopsy (EUS-LB)

Conditions

Interventions

PROCEDURE

PERCUTANEOUS LIVER BIOPSY (PLB)

Percutaneous liver biopsy using a 16 gauge (G) Trucut needle.

PROCEDURE

ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY (EUS-LB)

EUS-guided liver biopsy using a 19 gauge (G) Franseen core EUS needle

Sponsors & Collaborators

  • Hospital Clinico Universitario de Santiago

    lead OTHER

Principal Investigators

  • J. Enrique Dominguez-Muñoz, MD, PhD · Hospital Clínico Universitario de Santiago

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-19
Primary Completion
2022-09-01
Completion
2022-12-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05295537 on ClinicalTrials.gov